News

• In the literature: March 2023 highlights

  Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!

  -Read more-

• INNOVAHEART - the joint European workshop on the digital heart

  For the first time, five EU-funded projects - SimCardioTest, SIMCor, SimInSitu, the CSA EDITH and the EIT Health project inEurHeart - joint their forces to bring together the different actors of the in silico cardiovascular ecosystem at the one-day InnovaHeart workshop

  -Read more-

• SECRET international competition in cardiac modelling

  This competition on inference in complex physiological models is organised as part of the SofTMech Statistical Emulation and Translation Hub.

  -Read more-

• Non-animal Methods in Science and Regulation

  The 2022 EURL ECVAM Status Report describes research, dissemination and promotion activities undertaken by the Joint Research Centre’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) to further the uptake and use of non-animal methods and approaches in science and regulation.

  -Read more-

• Refinement Prize 2023: call for submissions

  The European Partnership for Alternative Approaches to Animal Testing (EPAA) has announced its 2023 Refinement Prize. Application deadline: 18 September 2023

  -Read more-

• Insilico Medicine Brings AI-Powered "ChatPandaGPT" to its Target Discovery Platform

  Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform.

  -Read more-